[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Andrew  Knowles M.Sc.", "title": "VP of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caitlin  Webster CIPD, M.Sc.", "title": "Director of Talent Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Clarke M.A.I.C.D., Ph.D.", "title": "Senior Vice President of Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Colussi Ph.D.", "title": "Site Head & Vice President of Australia", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Janna  Bednenko Ph.D.", "title": "Head of Protein Expression & Genetics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.74, "open": 3.73, "dayLow": 3.615, "dayHigh": 3.86, "regularMarketPreviousClose": 3.74, "regularMarketOpen": 3.73, "regularMarketDayLow": 3.615, "regularMarketDayHigh": 3.86, "payoutRatio": 0.0, "beta": 0.729, "forwardPE": -5.2463765, "volume": 2599659, "regularMarketVolume": 2599659, "averageVolume": 5100577, "averageVolume10days": 3120640, "averageDailyVolume10Day": 3120640, "bid": 2.75, "ask": 4.67, "bidSize": 2, "askSize": 2, "marketCap": 1083592832, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 6.515, "allTimeHigh": 71.91, "allTimeLow": 1.891, "priceToSalesTrailing12Months": 30.674955, "fiftyDayAverage": 4.6722, "twoHundredDayAverage": 3.657425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 730138880, "profitMargins": 0.0, "floatShares": 203200604, "sharesOutstanding": 299335048, "sharesShort": 50842609, "sharesShortPriorMonth": 55161166, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.1699, "heldPercentInsiders": 0.2292, "heldPercentInstitutions": 0.37605, "shortRatio": 10.14, "shortPercentOfFloat": 0.2203, "impliedSharesOutstanding": 299335048, "bookValue": 3.224, "priceToBook": 1.1228287, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -171676992, "trailingEps": -0.57, "forwardEps": -0.69, "enterpriseToRevenue": 20.669, "enterpriseToEbitda": -3.138, "52WeekChange": 0.3076923, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 3.62, "targetHighPrice": 16.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.83333, "targetMedianPrice": 9.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 495672000, "totalCashPerShare": 1.656, "ebitda": -232664000, "totalDebt": 142218000, "quickRatio": 8.485, "currentRatio": 10.103, "totalRevenue": 35325000, "debtToEquity": 14.752, "revenuePerShare": 0.119, "returnOnAssets": -0.10426, "returnOnEquity": -0.16814, "grossProfits": -147487008, "freeCashflow": -241470496, "operatingCashflow": -104552000, "revenueGrowth": 0.376, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -8.51792, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5100577, "fiftyTwoWeekLowChange": 1.7289999, "fiftyTwoWeekLowChangePercent": 0.91433096, "fiftyTwoWeekRange": "1.891 - 6.515", "fiftyTwoWeekHighChange": -2.895, "fiftyTwoWeekHighChangePercent": -0.44435918, "fiftyTwoWeekChangePercent": 30.76923, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "earningsCallTimestampStart": 1762466400, "earningsCallTimestampEnd": 1762466400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.57, "epsForward": -0.69, "epsCurrentYear": -0.6525, "priceEpsCurrentYear": -5.5478926, "fiftyDayAverageChange": -1.0522003, "fiftyDayAverageChangePercent": -0.22520445, "twoHundredDayAverageChange": -0.03742504, "twoHundredDayAverageChangePercent": -0.010232621, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 0.0, "postMarketPrice": 3.62, "postMarketChange": 0.0, "regularMarketChange": -0.12, "regularMarketDayRange": "3.615 - 3.86", "corporateActions": [], "postMarketTime": 1765587529, "regularMarketTime": 1765573202, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "marketState": "CLOSED", "regularMarketChangePercent": -3.20856, "regularMarketPrice": 3.62, "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]